DIADEM US INC

MISSION

To continue research, development and support commercialisation of AlzoSure® Predict in North America.

To continue to validate AlzoSure® Predict on multiple and numerous clinical cohorts of various demographics and ethnicities from North America.

COMPANY LEADERSHIP

PAUL KINNON

CEO
Paul has over 30 years of experience in the global life sciences industry, with the past 20 years of his executive career focused on Clinical Diagnostics and innovative products to improve patients’ lives. He has held leadership positions within PredictImmune, Transgenomic, ZyGEM Corp., Life Technologies (now ThermoFisher), Guava Technologies and Cellomics, raising more than $70m in funding, creating global partnerships and increasing shareholder return. Paul has spent half of his career living and working in the USA running global businesses, which gives him a novel and unique outlook on the global industry; additionally he sits on a number of Boards as non-executive director (NED) for Life Science companies.

DIANA SARACENI

Company Secretary 
She is Founder and Managing Partner of Panakes Partners SGR one of the major Med Tech venture investors in Europe. She brings almost 20 years of experience in Venture Capital investments on a large portfolio of successful companies in Italy and Europe

Contact:

Tel no.: 1 858 215 6250

Address:

Diadem US, Inc.
1117 S. California Avenue
Palo Alto, CA94304

Discover the latest opportunities

For job postings, the latest updates and more on the AlzoSure Predict® , click the button below.